RVMD - Revolution Medicines Inc
IEX Last Trade
42.7
0.900 2.108%
Share volume: 717,465
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$41.80
0.90
2.15%
Summary score
9%
Profitability
0%
Dept financing
4%
Liquidity
75%
Performance
4%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.55%
Return on assets
-7.66%
Return on sales
-2818.37%
Return on invested capital
-99.65%
Total debt ratio
15.01%
Debt ratio change over timeo
-1.22%
Current Ratio
11.72%
Quick Ratio
11.72%
Cash Position Ratio
11.45%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.77%
Return on assets
-9.69%
Return on sales
-13550.79%
Return on invested capital
-208.57%
Total debt ratio
12.31%
Debt ratio change over timeo
-1.13%
Current Ratio
13.24%
Quick Ratio
13.24%
Cash Position Ratio
13.05%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-6.72%
Return on assets
-7.38%
Return on sales
0%
Return on invested capital
-135.78%
Total debt ratio
9.58%
Debt ratio change over time
-1.02%
Current Ratio
18.45%
Quick Ratio
18.45%
Cash Position Ratio
18.18%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-88.15%
Return on assets
-89.6%
Return on sales
2988.71%
Return on invested capital
17.47%
Total debt ratio
-122.08%
Debt ratio change over time
-1.22%
Current Ratio
-16.48%
Quick Ratio
-16.48%
Cash Position Ratio
-16.09%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RVMD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.55% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.66% | 2.76% | 3.15% | 5.62% |
| Return on sales | -2818.37% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -99.65% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 15.01% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.22% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 13.24% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 13.24% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 13.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 9% | 22% |
| Short-term ratios | RVMD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.77% | 13.77% | 13.25% | 3.8% |
| Return on assets | -9.69% | 2.43% | 1.89% | 3.09% |
| Return on sales | -13550.79% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -208.57% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 12.31% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.13% | 46.38% | -72.08% | 1.51% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 13.24% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 13.24% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 13.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 10% | 25% |